Picture of Oxford Nanopore Technologies logo

ONT Oxford Nanopore Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

REG - Oxford Nanopore Tech - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250326:nRSZ3096Ca&default-theme=true

RNS Number : 3096C  Oxford Nanopore Technologies plc  26 March 2025

26 March 2025

Oxford Nanopore Technologies plc (the "Company")

Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

The Company has been notified that, on 25 March 2025, Kate Priestman, a
Non-Executive Director of the Company and a Person Discharging Managerial
Responsibilities, purchased a total of 17,726 ordinary shares in the Company
at a price of £1.120324 per share.

This announcement is made pursuant to the Company's obligations under Article
19(3) of the UK Market Abuse Regulation.

Kate Priestman - purchase of shares

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Kate Priestman
 2   Reason for the notification
 a)  Position/status                                              Non-Executive Director
 b)  Initial/Amendment notification                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Oxford Nanopore Technologies plc
 b)  LEI                                                          213800IRWQ2Q6M2CDW55
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument   Ordinary shares of £0.0001 each

     Identification code

                                                                  GB00BP6S8Z30
 b)  Nature of the transaction                                    Purchase of shares in the Company.
 c)  Price(s) and volume(s)

Price(s)    Volume(s)
                                                                  £1.120324   17,726
 d)  Aggregated information

     -     Aggregated volume                                      17,726 shares

     -     Aggregated price                                       £19,858.86
 e)  Date of the transaction                                      25 March 2025
 f)  Place of the transaction                                     London Stock Exchange (XLON)

d)

Aggregated information

-     Aggregated volume

-     Aggregated price

 

17,726 shares

£19,858.86

e)

Date of the transaction

25 March 2025

f)

Place of the transaction

London Stock Exchange (XLON)

Enquiries:

Investors

ir@nanoporetech.com

Media

media@nanoporetech.com

OxfordNanoporeTechnologies@teneo.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBSGDXGBDDGUL

Recent news on Oxford Nanopore Technologies

See all news